Document Detail


Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis.
MedLine Citation:
PMID:  20531249     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Human preterm infants with necrotizing enterocolitis (NEC) have increased circulating and luminal levels of platelet-activating factor (PAF) and decreased serum PAF-acetylhydrolase (PAF-AH), the enzyme that inactivates PAF. Formula supplemented with recombinant PAF-AH decreases NEC in a neonatal rat model. We hypothesized that endogenous PAF-AH contributes to neonatal intestinal homeostasis and therefore developed PAF-AH mice using standard approaches to study the role of this enzyme in the neonatal NEC model. After exposure to a well-established NEC model, intestinal tissues were evaluated for histology, proinflammatory cytokine mRNA synthesis, and death using standard techniques. We found that mortality rates were significantly lower in PAF-AH pups compared with wild-type controls before 24 h of life but surviving PAF-AH animals were more susceptible to NEC development compared with wild-type controls. Increased NEC incidence was associated with prominent inflammation characterized by elevated intestinal mRNA expression of sPLA2, inducible NOS, and CXCL1. In conclusion, the data support a protective role for endogenous PAF-AH in the development of NEC, and because preterm neonates have endogenous PAF-AH deficiency, this may place them at increased risk for disease.
Authors:
Jing Lu; Marissa Pierce; Andrew Franklin; Tamas Jilling; Diana M Stafforini; Michael Caplan
Related Documents :
9042079 - Stimulation of platelet-activating factor synthesis by neurotransmitters in salivary gl...
16414679 - Inhibition of platelet activating factor by ajmaline in platelets: in vitro and in vivo...
8642899 - Antiperoxidative effects of platelet activating factor antagonists against iron-depende...
2847729 - Platelet activating factor is a potent stimulant of the production of active oxygen spe...
8400419 - An in vitro method for assessing the effects of pro-inflammatory and anti-inflammatory ...
8386669 - Forskolin inhibits platelet-activating factor binding to platelet receptors independent...
21062249 - Anti-platelet therapy and aspirin resistance - clinically and chemically relevant?
19631969 - Management of bleeding and of invasive procedures in patients with platelet disorders a...
2375909 - Platelet storage pool deficiency: diagnosis in patients with prolonged bleeding times a...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Pediatric research     Volume:  68     ISSN:  1530-0447     ISO Abbreviation:  Pediatr. Res.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-13     Completed Date:  2010-11-30     Revised Date:  2011-09-13    
Medline Journal Info:
Nlm Unique ID:  0100714     Medline TA:  Pediatr Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  225-30     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Pritzker School of Medicine, University of Chicago, Evanston, IL 60201, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Alkyl-2-acetylglycerophosphocholine Esterase / blood,  deficiency*,  genetics
Analysis of Variance
Animals
Apoptosis / physiology
Chemokine CXCL1 / metabolism
Cytokines / metabolism
Enterocolitis, Necrotizing / enzymology*,  mortality,  pathology
Mice
Mice, Knockout
Nitric Oxide Synthase Type II / metabolism
Phospholipases A2, Secretory / metabolism
Platelet Activating Factor / metabolism
RNA, Messenger / metabolism*
Reverse Transcriptase Polymerase Chain Reaction
Grant Support
ID/Acronym/Agency:
AI058128/AI/NIAID NIH HHS; HD37581/HD/NICHD NIH HHS; HL35828/HL/NHLBI NIH HHS; R01 DK062960-03/DK/NIDDK NIH HHS; R01 DK062960-04/DK/NIDDK NIH HHS; R01 HD037581-09/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Chemokine CXCL1; 0/Cytokines; 0/Platelet Activating Factor; 0/RNA, Messenger; EC 1.14.13.39/Nitric Oxide Synthase Type II; EC 3.1.1.4/Phospholipases A2, Secretory; EC 3.1.1.47/1-Alkyl-2-acetylglycerophosphocholine Esterase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inflammatory response in preterm infants is induced early in life by oxygen and modulated by TPN.
Next Document:  Effects of dietary fish oil on intestinal adaptation in 20-day-old weanling rats after massive ileoc...